Combination cancer therapy with anti-psma antibodies

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 51/00 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2593574

This invention includes compositions and methods for combination cancer treatments, particularly involving at least one cytotoxic agent used in combination with an anti-PSMA monoclonal antibody.

La présente invention a trait à des compositions et des procédés pour des traitements du cancer de combinaison, notamment faisant intervenir au moins un agent cytotoxique en combinaison avec un anticorps monoclonal dirigé contre l'antigène membranaire spécifique de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination cancer therapy with anti-psma antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination cancer therapy with anti-psma antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination cancer therapy with anti-psma antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1737962

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.